EGFR and neoplasm: In EGFR WT A549 and L858R/T790M mutant H1975 xenograft tumors, gefitinib had no visible effect on tumor growth, whereas deguelin markedly reduced tumor size at the treatment endpoint (Fig. 7e–h).